# Avanos Medical Inc. (AVNS) fundamentals

Data as of 2026-09-08. NYSE, United States. Sector: Healthcare / Health Care Technology. Price $24.99, market value $1.2 billion.

## Valuation
- **P/E (trailing): n/a** (negative earnings). Avanos Medical Inc. reported negative earnings over the last twelve months, so the P/E is not meaningful; use price-to-sales, EV/EBITDA and free-cash-flow yield instead.
- **PEG: 0.25**. A PEG of 0.25 means the P/E is low relative to expected earnings growth: the market is not paying much for that growth.
- **Price / sales: 1.7×**. Each dollar of revenue is priced at 1.7×.
- **Price / book: 1.5×**. The shares trade at 1.5× book value; book value is a meaningful part of the valuation.
- **Free-cash-flow yield: 3.7%** (5-yr avg 6.1%). Free cash flow equals 3.7% of the market value, below its five-year average of 6.1%, so the shares are pricier on cash than usual.

## Profitability
- **Gross margin: 50.5%**. Avanos Medical Inc. keeps 50.5% of revenue after the direct cost of what it sells.
- **Operating margin: -8.8%**. Operating margin is negative: the business loses money before interest and tax.
- **Net margin: -10.4%**. The company reported a net loss over the last twelve months.
- **Return on equity: -9.4%**. Return on equity is negative because earnings are negative.
- **Return on invested capital: -6.2%**. Return on all capital, debt included, is -6.2%: close to or below the cost of capital, so growth may not create value.
- **Return on assets: -6.8%**. Each dollar of assets produces -6.8% of profit.

## Growth
- **Revenue growth (1 yr): 1.9%** (3-yr 0.8%/yr, 5-yr -0.4%/yr). Revenue grew 1.9% over the last year, against -0.4% a year compounded over five years: growth is accelerating.
- **EPS growth (1 yr): 81.6%**. Earnings per share rose 81.6%, faster than revenue, so margins expanded or the share count shrank.
- **Free-cash-flow growth (3 yr): -15.6%/yr**. Free cash flow has compounded at -15.6% a year over three years.

## Financial health
- **Debt to equity: 0.13**. Debt is 0.13 times equity: a conservative balance sheet.
- **Net debt / EBITDA: net cash**. Avanos Medical Inc. holds more cash than debt.
- **Altman Z-score: 3.86**. A Z-score of 3.86 places the company in the safe zone for bankruptcy risk.
- **Piotroski F-score: 5/9**. 5 of 9 checks pass: mixed.

## Dividends
- **Dividend: none**. Avanos Medical Inc. does not currently pay a dividend.

## Price and momentum
- **From 52-week high: -2.0%** (161.7% above the low). Trading within 5% of its 52-week high.
- **200-day average: above**. The price sits above its 200-day moving average, the usual definition of an uptrend.
- **RSI (14-day): 62**. An RSI of 62 is neutral.
- **Beta (1 yr): 1.20** (volatility 78%). Beta of 1.20 against the S&P 500: the shares move roughly with the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=AVNS · Page: https://foliofundamentals.com/stocks/avns

Not investment advice.